CAPR Icon

$CAPR

$CAPR

Capricor Therapeutics

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatm...

Stocks

Total Asset Value

$5,216

+1,782.12%from 30d ago

Holders

48

+140.00%from 30d ago

Monthly Transfer Volume

$49.44K

+50.38%from 30d ago

Tokenized Stock Metrics

Tokenized Public Stocks

10 Total